Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline.
Changchuan JiangStacey A FedewaYumeng WenAhmedin JemalXuesong HanPublished in: Prostate cancer and prostatic diseases (2020)
Between 2015 and 2018, there was no significant increase in the PSA-based prostate cancer screening. However, a significant increasing trend in SDM was observed, especially in men aged 55-69 years.
Keyphrases